Key result
Progression of valve dysfunction occurred in 36.4% of dialysis patients during follow-up, with hyperparathyroidism being the only variable significantly associated with mitral valve disease.
Hyperparathyroidism is independently associated with mitral valve disease progression in dialysis patients.
Progression of valvular heart disease in dialysis patients: how to stop it?Progressão da doença valvar cardíaca nos pacientes em diálise: como evitá-la?one degree of valve dysfunction (none to mild, mild to moderate, or moderate to severe) was observed in 36.4% of patients during follow-up.Longer time in dialysis was significantly associated with the presence of mitral and tricuspid valve disease in univariate analyses, but that association was no longer significant after adjustment for age, diabetes status, hyperparathyroidism, and type of renal replacement therapy.Hyperparathyroidism was the only variable significantly associated with mitral valve disease after multivariate analysis.
No takes yet. Share an insight, caveat, or question.
Eduardo Leal Adam (2024) conducted an editorial in Valvular heart disease in dialysis patients. Hyperparathyroidism was evaluated on Progression of valve dysfunction. Progression of valve dysfunction occurred in 36.4% of dialysis patients during follow-up, with hyperparathyroidism being the only variable significantly associated with mitral valve disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: